Advisory Services Network’s Maravai LifeSciences MRVI Stock Holding History

Advisory Services Network’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.03K	Buy	+2,483	New	+$8.42K	﹤0.01%	3723
2025 Q4	–	Sell	-1,549	Closed	-$4.45K	–	3342
2025 Q3	$4.45K	Buy	+1,549	New	+$3.96K	﹤0.01%	3566
2023 Q2	–	Sell	-10	Closed	-$140	–	2790
2023 Q1	$140	Hold	10	–	–	﹤0.01%	3883
2022 Q4	$143	Buy	+10	New	+$157	﹤0.01%	3889
2021 Q3	–	Sell	-36	Closed	-$2K	–	2528
2021 Q2	$2K	Buy	+36	New	+$1.4K	﹤0.01%	3336
2021 Q1	–	Sell	-21	Closed	-$1K	–	2333
2020 Q4	$1K	Buy	+21	New	+$585	﹤0.01%	3162

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advisory Services Network's MRVI Position: Q1 2026 in Review

Advisory Services Network opened a new position in Maravai LifeSciences (MRVI) in Q1 2026: 2,483 shares worth $7.03K. The stake represents ﹤0.01% of the portfolio and ranks #3723 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in MRVI as recently as Q3 2025.

Advisory Services Network first reported a position in MRVI in Q4 2020 and has held it in 6 quarters since. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Advisory Services Network held 2,483 shares of Maravai LifeSciences worth $7.03K as of Q1 2026.
Maravai LifeSciences was a new Advisory Services Network position in Q1 2026.
Maravai LifeSciences made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #3723 holding.
Advisory Services Network first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 6 quarters since.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.